medigraphic.com

2008, Number 3

<< Back Next >>

Rev Hosp Jua Mex 2008; 75 (3)

Degenerative spondylolisthesis and joint disease in adult people

Rafael H

Language: English
References: 50
Page: 218-222
PDF size: 148.04 Kb.


ABSTRACT

In base to anatomical, hormonal and pathological findings in the spine and peripheral joints in patients with degenerative changes, I believe that both of them are caused by progressive ischemia due to atherosclerosis and growth hormone deficiency in our body. The pathological changes are initiated in the intervertebral discs (about 30 years) and several years later (about 50 years), in the peripheral joints. Thereby, in my opinion, the treatment must be directed against the atherosclerosis and growth hormone replacement therapy.


REFERENCES

  1. Ratcliffe JF. The anatomy of fourth and fifth lumbar arteries in humans: An arteriographic study in one hundred live subjects. J Anat 1982; 135: 735-61.

  2. Svensson HO, Vedin A, Wilhelmsson C, Andersson GB. Low back pain in relation to other diseases and cadiovascular risk factors. Spine 1883; 8: 277-85.

  3. Ratcliffe JF. The arterial anatomy of the developing human dorsal and lumbar vertebral body. A microarteriographic study. J Anat 1981; 133: 625-38.

  4. Texon M. The hemodynamic concept of atherosclerosis. Bull NY Acad Med 1960; 36: 263-74.

  5. Rogoff SM, Lipchik EO. Lumbar aortography in atherosclerosis. In: Abrams HL (ed.). Angiography. 2nd Ed. New York: Churchill Linvingstone; 1970, p. 737-57.

  6. Kurunlahi M, Tervonen O, Vanharanta H, Jikko E, Suramo I. Association of atherosclerosis with low back pain and the degree of disc degeneration. Spine 1999; 24: 2080-4.

  7. Rafael H. Low back pain. J Neurosurg 2007; 7(7): 114-6.

  8. Rafael H. Aortic atherosclerosis and lumbar spondylolisthesis. J Neurol Sci (Turk) 2007; 24(4): 260-2.

  9. Fawcett DW. A texbook of histology. Chapter 7. New York: Chapman & Hall; 1994, p. 182-93.

  10. Testud L, Latarjet A. Anatomía humana. Tomo I. Barcelona: Salvat Edit.; 1979, p. 1-43.

  11. De Palma AF, Rothman RH. The intervertebral disc. Chapter I. Philadelphia: W.W.Saunders Co.; 1971, p. 1-29.

  12. Rafael H, Ayulo V, Lucar A. Patogenia de la aterosclerosis: Base hemodinámica y factores de riesgo. Rev Climaterio 2003; 6(33): 125-8.

  13. Doiata M, Kanatanic T, Harada T, Mizuno K. Inmunohistologic atudy of the rupture intervertebral disc of the lumbar spine. Spine 1996; 21: 235-41.

  14. Rosenberg NJ. Degenerative spondylolisthesis. Clin Orthopaedic and Related Res 1976; 117: 112-20.

  15. Boleaga-Durán B, Fiesco-Gómez LE. Enfermedad degenerativa de la columna lumbosacra. Correlación clínica y por resonancia magnética. Cir Ciruj (Méx) 2006; 74(2): 101-5.

  16. Radin EL, Paul IL, Rose RM. Role of mechanical factors in pathogenesis of primary osteoarthritis. Lancet 1972; I: 519-21.

  17. Martyn CN, Greenwald SE. Impaired synthesis of elastine in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension. Lancet 1997; 350: 953-5.

  18. Ross R, Glonset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 1976; 295: 369-76.

  19. Komotar RJ, Wilson DA, Mocco J, et al. Natural history of intracranial atherosclerosis. Neurosurgery 2006; 58(4): 595-601.

  20. Hass WK, Field WS, North RR, Kricheff II, Chase NE, Bauer RB. Joint study of extracranial arterial occlusion II: Arteriographic, techniques, siters, and complications. JAMA 1968; 203: 961-8.

  21. Flora GC, Baker SAP, Loewenson RB, Klassen AC. A comparative study of cerebral atherosclerosis in males and females. Circulation 1968; 38: 859-69.

  22. Scharrer E, Gaupp R. Neuere befunde and nucleus supraopticus und nucleus paraventricularis des menschen. Z Neural 1933; 148: 766-72.

  23. Finley KH. The capillary bed of the paraventricular and supraoptic nuclei of the hypothalamus. Res Publ Ass Nerv Ment Dis 1938; 18: 94-109.

  24. Page RB, Bergland RM. The neurohypophyseal capillary bed. I. Anatomy and arterial supply. Am J Anat 1977; 148: 345-51.

  25. Felten DL, Crutcher KA. Neuronal-vascular relationships in the raphe nuclei, locus coeruleus and substantia nigra in primates. Am J Anat 1979; 155: 467-72.

  26. Martin JB. Neural regulation of growth hormone secretion. N Engl J Med 1973; 288: 1384-92.

  27. Rafael H. Rejuvenation after omental trasnplantation on the optic chiasma and carotid bifurcation. Case Rep Clin Pract Rev 2006; 7: 48-51.

  28. Rafael H. Stem cells. J Neurosurg 2008; 108(4): 841-2.

  29. Rudman D. Growth hormone, body composition and agin. J Anat Geriat Soc 1985; 33: 800-7.

  30. Vance ML. Growth hormone for the elderly? N Engl J Med 1990; 323: 52-4.

  31. Leal S, Andrade JP, Paula-Barobosa MM, Madeira MD. Arcuate nucleus of the hypothalamus. Effect of age and sex. J Comp Neurol 1998; 401: 65-88.

  32. Altman J. Are new neurons formed in the brain of adult mammal? Science 1962; 135: 1127-8.

  33. Altman J, Das GD. Autoradiographic and histological evidences of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965; 124: 319-36.

  34. Rietze RL, Bartlett PF. Purification of a pluripotent neural stem cells from adult mouse brain. Nature 2001; 412: 736-9.

  35. Rafael H, Fernández E, Ayulo V, Dávila L. Weight loss following omental transplantation on the anterior perforated space. Case Rep Clin Pract Rev 2003; 4(3): 160-2.

  36. Rafael H, Mego R, Moromizato P, García W, Rodriguez J. Omental transplantation forr type 2 diabetes mellitus: A report of two cases. Case Rep Clin Pract Rev 2004; 5: 481-48.

  37. Rafael H. Cerebral atherosclerosis and oxidative stress in some challenging diseases. J Neurol Sci (Turk) 2004; 21(4): 343-9.

  38. Blouin AM, Thannickal TC, Warly PF, Baraban JM, Reti IM, Siegel JM. Narp immunostaining of human hypocretin (orexin) neurons. Neurology 2005; 65(8): 1189-92.

  39. Rafael H. Hypothalamic ischemia and metabolic syndrome. Med Sci Monit 2006; 12(9): LE17-18.

  40. Rafael H. Isquemia hipotalámica y diabetes mellitus tipo 2. Rev Mex Cardiol 2007; 18(4): 185-7.

  41. Corpas E, Hatman SM, Blackman MR. Human growth hormone and human aging. Endocrine Rev 1993; 14: 20-39.

  42. Rudman D, Felle AG, Nagray HS, et al. Effects of human growth hormone in man over 60 years old. N Engl J Med 1990; 323: 1-6.

  43. Kerckoff H. Manejo de la somatotropina sintética anti-envejecimiento. Rev Climaterio 2004; 7(42): 245-9.

  44. Clemmons DR, Vyk JJ. Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab 1984; 13: 113-43.

  45. Morgan HE, Jefferson LS, Wolpert EB, Rannels DE. Regulation of protein synthesis in heart muscle. II Effects of aminoacid levels and insulin on ribosomal aggregation. J Biol Chem 1971; 246: 2163-70.

  46. Cheek DB, Hill DE. Effect of growth hormone on cell and somatic growth. In: Knobil E, Sawyer WH (eds.). Handbook of Pysiology. Sect 7. Vol 4. Am Physiol Soc 1974: 159-86.

  47. Parker ML, Hammond JM, Daughaday WH. The ariginine provocative test. An aid in diagnosis of hyposomatotropism. J Clin Endocrinol 1967; 27: 1129-36.

  48. Jeanloz BW. The nomenclature of acid mucopolysaccharides. Arthritis Rheum 1960; 3: 323-7.

  49. Verhoeven HC, De RL. Growth hormone replacement therapy: Is it safe? The Aging Male 2005; 8(2): 121-122 (Abstract).

  50. Rafael H. Hypothalamic ischemia and premature aging. Med Sci Monit 2007; 13(7): LE9-10.




2020     |     www.medigraphic.com